S&P 500   3,333.17 (-0.48%)
DOW   27,290.92 (-0.35%)
QQQ   269.41 (-1.90%)
AAPL   441.70 (-3.05%)
MSFT   211.09 (-2.43%)
FB   266.52 (+0.47%)
GOOGL   1,489.59 (-1.02%)
AMZN   3,143.18 (-2.54%)
NVDA   441.60 (-2.61%)
CGC   16.67 (-4.85%)
BABA   250.21 (-5.82%)
TSLA   1,418.26 (-4.79%)
MU   48.21 (-1.01%)
GE   6.42 (+1.42%)
AMD   83.20 (-4.05%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.10 (-2.04%)
GILD   69.00 (+0.28%)
NFLX   487.14 (-4.31%)
DIS   129.32 (-1.15%)
BAC   26.00 (+2.08%)
BA   169.02 (-1.85%)
S&P 500   3,333.17 (-0.48%)
DOW   27,290.92 (-0.35%)
QQQ   269.41 (-1.90%)
AAPL   441.70 (-3.05%)
MSFT   211.09 (-2.43%)
FB   266.52 (+0.47%)
GOOGL   1,489.59 (-1.02%)
AMZN   3,143.18 (-2.54%)
NVDA   441.60 (-2.61%)
CGC   16.67 (-4.85%)
BABA   250.21 (-5.82%)
TSLA   1,418.26 (-4.79%)
MU   48.21 (-1.01%)
GE   6.42 (+1.42%)
AMD   83.20 (-4.05%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.10 (-2.04%)
GILD   69.00 (+0.28%)
NFLX   487.14 (-4.31%)
DIS   129.32 (-1.15%)
BAC   26.00 (+2.08%)
BA   169.02 (-1.85%)
S&P 500   3,333.17 (-0.48%)
DOW   27,290.92 (-0.35%)
QQQ   269.41 (-1.90%)
AAPL   441.70 (-3.05%)
MSFT   211.09 (-2.43%)
FB   266.52 (+0.47%)
GOOGL   1,489.59 (-1.02%)
AMZN   3,143.18 (-2.54%)
NVDA   441.60 (-2.61%)
CGC   16.67 (-4.85%)
BABA   250.21 (-5.82%)
TSLA   1,418.26 (-4.79%)
MU   48.21 (-1.01%)
GE   6.42 (+1.42%)
AMD   83.20 (-4.05%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.10 (-2.04%)
GILD   69.00 (+0.28%)
NFLX   487.14 (-4.31%)
DIS   129.32 (-1.15%)
BAC   26.00 (+2.08%)
BA   169.02 (-1.85%)
S&P 500   3,333.17 (-0.48%)
DOW   27,290.92 (-0.35%)
QQQ   269.41 (-1.90%)
AAPL   441.70 (-3.05%)
MSFT   211.09 (-2.43%)
FB   266.52 (+0.47%)
GOOGL   1,489.59 (-1.02%)
AMZN   3,143.18 (-2.54%)
NVDA   441.60 (-2.61%)
CGC   16.67 (-4.85%)
BABA   250.21 (-5.82%)
TSLA   1,418.26 (-4.79%)
MU   48.21 (-1.01%)
GE   6.42 (+1.42%)
AMD   83.20 (-4.05%)
T   29.95 (+0.37%)
F   6.85 (-1.15%)
ACB   10.10 (-2.04%)
GILD   69.00 (+0.28%)
NFLX   487.14 (-4.31%)
DIS   129.32 (-1.15%)
BAC   26.00 (+2.08%)
BA   169.02 (-1.85%)
Log in

LON:FUMFutura Medical Share Price, Forecast & News

GBX 17.50
+0.40 (+2.34 %)
(As of 08/7/2020 12:02 PM ET)
Add
Compare
Today's Range
16.65
Now: GBX 17.50
17.99
50-Day Range
12.75
MA: GBX 15.67
18.75
52-Week Range
0.15
Now: GBX 17.50
47.90
Volume396,504 shs
Average Volume415,619 shs
Market Capitalization£42.98 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Futura Medical plc develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that incorporates an erectogenic gel to help men maintain a firmer erection during intercourse whilst wearing a condom. It is also developing MED2002, a topical gel applied directly to the penis for the treatment of male erectile dysfunction that is in Final Phase III program. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; TIB200, a topical ibuprofen pain relief gel; and SPR300, a topical methyl salicylate pain relief gel. It operates in the Middle East/ROW, the United States, and Europe. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Read More
Futura Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1483-685670

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£31,778.00
Cash FlowGBX 1.42 per share

Profitability

Miscellaneous

Employees15
Market Cap£42.98 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 17.50
+0.40 (+2.34 %)
(As of 08/7/2020 12:02 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FUM News and Ratings via Email

Sign-up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Futura Medical (LON:FUM) Frequently Asked Questions

How has Futura Medical's stock been impacted by COVID-19 (Coronavirus)?

Futura Medical's stock was trading at GBX 11.13 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, FUM stock has increased by 57.3% and is now trading at GBX 17.50.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Futura Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Futura Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Futura Medical
.

How were Futura Medical's earnings last quarter?

Futura Medical plc. (LON:FUM) issued its earnings results on Wednesday, April, 1st. The company reported ($4.36) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($4.20) by $0.16.
View Futura Medical's earnings history
.

What price target have analysts set for FUM?

1 brokers have issued 1 year price targets for Futura Medical's stock. Their forecasts range from GBX 55 to GBX 55. On average, they anticipate Futura Medical's share price to reach GBX 55 in the next twelve months. This suggests a possible upside of 214.3% from the stock's current price.
View analysts' price targets for Futura Medical
.

Has Futura Medical been receiving favorable news coverage?

News headlines about FUM stock have trended positive this week, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Futura Medical earned a daily sentiment score of 2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future.
View the latest news about Futura Medical
.

Who are some of Futura Medical's key competitors?

What other stocks do shareholders of Futura Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), Tullow Oil (TLW), The People's Operator (TPOP), CityFibre Infrastructure (CITY) and Paysafe Group (PAYS).

Who are Futura Medical's key executives?

Futura Medical's management team includes the following people:
  • Mr. James Henry Barder, CEO & Exec. Director (Age 59)
  • Mr. Kenneth William James, Head of R&D and Exec. Director (Age 66)
  • Ms. Angela Hildreth, COO, Fin. Director, Company Sec. & Director
  • Dr. William Duncan Potter, Chief Scientific Officer & Adviser to the Board (Age 71)

What is Futura Medical's stock symbol?

Futura Medical trades on the London Stock Exchange (LON) under the ticker symbol "FUM."

How do I buy shares of Futura Medical?

Shares of FUM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Futura Medical's stock price today?

One share of FUM stock can currently be purchased for approximately GBX 17.50.

How big of a company is Futura Medical?

Futura Medical has a market capitalization of £42.98 million and generates £31,778.00 in revenue each year. Futura Medical employs 15 workers across the globe.

What is Futura Medical's official website?

The official website for Futura Medical is www.futuramedical.com.

How can I contact Futura Medical?

Futura Medical's mailing address is 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom. The company can be reached via phone at +44-1483-685670.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.